A primer on the current state-of-the-science neoadjuvant and adjuvant therapy for patients with locally advanced rectal adenocarcinomas

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Yorio, Jeffrey T ^a   Bhadkamkar, Nishin A ^b   Kee, Bryan K ^a   Garrett, Christopher R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866181171     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/863034     Document Type: Review

References (49)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29
3. Rosen L., Veidenheimer M. C., Coller J. A., Corman M. L., Mortality, morbidity, and patterns of recurrence after abdominoperineal resection for cancer of the rectum. Diseases of the Colon and Rectum 1982 25 3 202 208 2-s2.0-0020032062 (Pubitemid 12104280)
4. Landau D., Garrett C., Chodkiewicz C., A case of primary squamous cell colon cancer. Journal of Oncology Pharmacy Practice 2007 13 1 47 48 2-s2.0-34250220712 10.1177/1078155207072493 (Pubitemid 46894738)
5. Dong Y., Wang J., Ma H., Zhou H., Lu G., Zhou X., Primary adenosquamous carcinoma of the colon: report of five cases. Surgery Today 2009 39 7 619 623 2-s2.0-67651159057 10.1007/s00595-008-3884-6
6. Koura A. N., Giacco G. G., Curley S. A., Skibber J. M., Feig B. W., Ellis L. M., Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer 1997 79 7 1294 1298 10.1002/(SICI)1097-0142(19970401)79:71294::AID-CNCR4>3.0.CO;2-H (Pubitemid 27143234)
7. Homsi J., Garrett C., Melanoma of the anal canal: a case series. Diseases of the Colon and Rectum 2007 50 7 1004 1010 2-s2.0-34447092532 10.1007/s10350-007-0242-5 (Pubitemid 47030194)
8. Morgan C. N., The surgical anatomy of the anal canal and rectum. Postgraduate Medical Journal 1936 130 7 287 314
9. Memon S., Keating J. P., Cooke H. S., Dennett E. R., A study into external rectal anatomy: improving patient selection for radiotherapy for rectal cancer. Diseases of the Colon and Rectum 2009 52 1 87 90 2-s2.0-64049102339 10.1007/DCR.0b013e3181973a91
10. Cass A. W., Million R. R., Pfaff W. W., Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976 37 6 2861 2865 2-s2.0-0017183752
11. Engstrom P. F., Arnoletti J. P., Benson A. B., Berlin J. D., Berry J. M., Chen Y. J., Choti M. A., Cooper H. S., Dilawari R. A., Early D. S., Enzinger P. C., Fakih M. G., Fleshman J., Fuchs C., Grem J. L., Knol J. A., Leong L. A., Lin E., Mulcahy M. F., Rohren E., Ryan D. P., Saltz L., Shibata D., Skibber J. M., Small W., Sofocleous C., Thomas J., Venook A. P., Willett C., Anal carcinoma: clinical practice guidelines in oncology: rectal cancer. Journal of the National Comprehensive Cancer Network 2010 8 1 838 881
12. Gunderson L. L., Sargent D. J., Tepper J. E., Wolmark N., O'Connell M. J., Begovic M., Allmer C., Colangelo L., Smalley S. R., Haller D. G., Martenson J. A., Mayer R. J., Rich T. A., Ajani J. A., MacDonald J. S., Willett C. G., Goldberg R. M., Impact of t and n stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. Journal of Clinical Oncology 2004 22 10 1785 1796 2-s2.0-3042825347 10.1200/JCO.2004.08.173 (Pubitemid 41095168)
13. McGinn C. J., Kinsella T. J., The clinical rationale for S-phase radiosensitization in human tumors. Current Problems in Cancer 1993 17 5 277 321 2-s2.0-0027655796
14. Gastrointestinal Tumor Study Group, Prolongation of the disease-free interval in surgically treated rectal carcinoma. The New England Journal of Medicine 1985 312 23 1465 1472
15. Douglas H. O. Jr., Moertel C. G., Mayer R. J., Survival after postoperative combination treatment of rectal cancer. The New England Journal of Medicine 1986 315 20 1294 1295 2-s2.0-0022876509 (Pubitemid 17049694)
16. Haller D. G., Tabernero J., Maroun J., De Braud F., Price T., Van Cutsem E., Hill M., Gilberg F., Rittweger K., Schmoll H. J., Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. Journal of Clinical Oncology 2011 29 11 1465 1471 2-s2.0-79955040540 10.1200/JCO.2010.33.6297
17. Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A., Twito D. I., Morton R. F., Veeder M. H., Witzig T. E., Cha S., Vidyarthi C., Effective surgical adjuvant therapy for high-risk rectal carcinoma. The New England Journal of Medicine 1991 324 11 709 715 2-s2.0-0026071185
18. Hall W. H., Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990 264 11 1444 1450 2-s2.0-0025710611 10.1001/jama.264.11.1444 (Pubitemid 20331943)
19. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerman D. L., Fisher E. R., Caplan R., Jones J., Lerner H., Gordon P., Feldman M., Cruz A., Legault-Poisson S., Wexler M., Lawrence W., Robidoux A., Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from nsabp protocol R-01. Journal of the National Cancer Institute 1988 80 1 21 29 2-s2.0-0023836214 (Pubitemid 18076565)
20. Wolmark N., Wieand H. S., Hyams D. M., Colangelo L., Dimitrov N. V., Romond E. H., Wexler M., Prager D., Cruz A. B., Gordon P. H., Petrelli N. J., Deutsch M., Mamounas E., Wickerham D. L., Fisher E. R., Rockette H., Fisher B., Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: national surgical adjuvant breast and bowel project protocol R-02. Journal of the National Cancer Institute 2000 92 5 388 396 2-s2.0-0034162884 (Pubitemid 30154820)
21. Påhlman L., Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England Journal of Medicine 1997 336 14 980 987 2-s2.0-1842377447 10.1056/NEJM199704033361402 (Pubitemid 27152783)
22. Folkesson J., Birgisson H., Pahlman L., Cedermark B., Glimelius B., Gunnarsson U., Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. Journal of Clinical Oncology 2005 23 24 5644 5650 2-s2.0-24944534960 10.1200/JCO.2005.08.144
23. MacFarlane J. K., Ryall R. D. H., Heald R. J., Mesorectal excision for rectal cancer. The Lancet 1993 341 8843 457 460 2-s2.0-0027404137 10.1016/0140-6736(93)90207-W (Pubitemid 23054519)
24. Kapiteijn E., Marijnen C. A. M., Nagtegaal I. D., Putter H., Steup W. H., Wiggers T., Rutten H. J. T., Pahlman L., Glimelius B., Van Krieken J. H. J. M., Leer J. W. H., Van De Velde C. J. H., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. The New England Journal of Medicine 2001 345 9 638 646 2-s2.0-0035975394 10.1056/NEJMoa010580
25. Peeters K. C. M. J., Marijnen C. A. M., Nagtegaal I. D., Kranenbarg E. K., Putter H., Wiggers T., Rutten H., Pahlman L., Glimelius B., Leer J. W., Van De Velde C. J. H., The tme trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Annals of Surgery 2007 246 5 693 701 2-s2.0-34548557656 10.1097/01.sla.0000257358.56863.ce (Pubitemid 350035641)
26. Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C. F., Karstens J. H., Liersch T., Schmidberger H., Raab R., Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England Journal of Medicine 2004 351 17 1731 1810 2-s2.0-6044226542 10.1056/NEJMoa040694 (Pubitemid 39383208)
27. Bosset J. F., Collette L., Calais G., Mineur L., Maingon P., Radosevic-Jelic L., Daban A., Bardet E., Beny A., Ollier J. C., Chemotherapy with preoperative radiotherapy in rectal cancer. The New England Journal of Medicine 2006 355 11 1114 1123 2-s2.0-33748676449 10.1056/NEJMoa060829 (Pubitemid 44394918)
28. O'Connell M. J., Martenson J. A., Wieand H. S., Krook J. E., Macdonald J. S., Haller D. G., Mayer R. J., Gunderson L. L., Rich T. A., Improving adjuvant therapy for rectal cancer by combining protracted- infusion fluorouracil with radiation therapy after curative surgery. The New England Journal of Medicine 1994 331 8 502 507 2-s2.0-0028136295 10.1056/NEJM199408253310803 (Pubitemid 24256753)
29. Roh M. S., Colangelo L. H., O'Connell M. J., Yothers G., Deutsch M., Allegra C. J., Kahlenberg M. S., Baez-Diaz L., Ursiny C. S., Petrelli N. J., Wolmark N., Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. Journal of Clinical Oncology 2009 27 31 5124 5130 2-s2.0-70449726857 10.1200/JCO.2009.22.0467
30. Ngan S. Y. K., Michael M., Mackay J., McKendrick J., Leong T., Joon D. L., Zalcberg J. R., A phase i trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. British Journal of Cancer 2004 91 6 1019 1024 2-s2.0-5044220099 10.1038/sj.bjc.6602106 (Pubitemid 39336237)
31. Twelves C., Wong A., Nowacki M. P., Abt M., Burris H., Carrato A., Cassidy J., Cervantes A., Fagerberg J., Georgoulias V., Husseini F., Jodrell D., Koralewski P., Kröning H., Maroun J., Marschner N., McKendrick J., Pawlicki M., Rosso R., Schüller J., Seitz J. F., Stabuc B., Tujakowski J., Van Hazel G., Zaluski J., Scheithauer W., Capecitabine as adjuvant treatment for stage III colon cancer. The New England Journal of Medicine 2005 352 26 2696 2704 2-s2.0-21244497388 10.1056/NEJMoa043116 (Pubitemid 41007824)
32. Hofheinz R., Wenz F. K., Post S., Capecitabine versus 5-fluorouracil-based (neo)adjuvant chemoradiotherapy for locally advanced rectal cancer: long-term results of a randomized, phase III trial. Journal of Clinical Oncology 2011 29. Abstract no. 3504
33. Roh M. S., Yothers G. A., O'Connell M. J., The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. Journal of Clinical Oncology 2011 29. Abstract no. 3503
34. André T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., Topham C., Zaninelli M., Clingan P., Bridgewater J., Tabah-Fisch I., De Gramont A., Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. The New England Journal of Medicine 2004 350 23 2343 2351 2-s2.0-2542615200 10.1056/NEJMoa032709 (Pubitemid 38702845)
35. Goldberg R. M., Sargent D. J., Morton R. F., Fuchs C. S., Ramanathan R. K., Williamson S. K., Findlay B. P., Pitot H. C., Alberts S. R., A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2004 22 1 23 30 2-s2.0-1842569206 10.1200/JCO.2004.09.046 (Pubitemid 41095110)
36. Aschele C., Pinto C., Cordio S., Final safety findings from a randomized phase III trial of preoperative FU-based chemoradiation +/- weekly oxaliplatin as neoadjuvant therapy for patients with locally advanced rectal cancer: the STAR (Studio Terapia Adiuvante Retto)-01 randomized trial. Gastrointestinal Cancers Symposium 2009. Abstract no. LBA290
37. Roedel C., Becker H., Fietkau R., Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: first results of the German CAO/ARO/AIO-04 randomized phase III trial. Journal of Clinical Oncology 2011 29. Abstract no. LBA3505
38. Gérard J. P., Azria D., Gourgou-Bourgade S., Martel-Laffay I., Hennequin C., Etienne P. L., Vendrely V., François E., De La Roche G., Bouché O., Mirabel X., Denis B., Mineur L., Berdah J. F., Mahé M. A., Bécouarn Y., Dupuis O., Lledo G., Montoto-Grillot C., Conroy T., Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase iii trial accord 12/0405-prodige 2. Journal of Clinical Oncology 2010 28 10 1638 1644 2-s2.0-77950495945 10.1200/JCO.2009.25.8376
39. André T., Boni C., Navarro M., Tabernero J., Hickish T., Topham C., Bonetti A., Clingan P., Bridgewater J., Rivera F., De Gramont A., Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the mosaic trial. Journal of Clinical Oncology 2009 27 19 3109 3116 2-s2.0-67650315187 10.1200/JCO.2008.20. 6771
40. Koukourakis G. V., gkoyokoyrakis@yahoo.gr Sotiropoulou-Lontou A., Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer. Clinical and Translational Oncology 2011 13 10 710 714 10.1007/s12094-011-0720-z
41. Hoda D., Simon G. R., Garrett C. R., Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab. Therapeutics and Clinical Risk Management 2008 4 6 1221 1227 2-s2.0-61549138171
42. Garrett C. R., Eng C., Cetuximab in the treatment of patients with colorectal cancer. Expert Opinion on Biological Therapy 2011 11 7 937 949 2-s2.0-79958043820 10.1517/14712598.2011.582464
43. Crane C. H., Eng C., Feig B. W., Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Journal of Clinical Oncology 2008 26. Abstract no. 4091
44. Willett C., Duda D., Boucher Y., Phase III study of neoadjuvant bevacizumab with radiation therapy and 5-fluorouracil in patients with rectal cancer: initial results. Journal of Clinical Oncology 2007 25. Abstract no. 4091
45. Dipetrillo T., Pricolo V., Lagares-Garcia J., Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation in clinical stage II-III rectal cancer. Journal of Clinical Oncology 2009 27. Abstract no. 4105
46. Elvira G., Torrecillas L., Cervantes G., Phase II study of bevacizumab and cetuximab as neoadjuvant treatment in locally advanced rectal cancer: a preliminary security report. Journal of Clinical Oncology 2011 29. Abstract no. 627
47. Dewdney A., Capdevila J., Glimelius B., EXPERT-C: a randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy and chemoradiation with or without cetuximab followed by total mesorectal excision in patients with MRI-defined, high-risk rectal cancer. Journal of Clinical Oncology 2011 29. Abstract no. 3513
48. Nash G. M., Weiss A., Dasgupta R., Gonen M., Guillem J. G., Wong W. D., Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Diseases of the Colon and Rectum 2010 53 10 1365 1373 2-s2.0-78049358127 10.1007/DCR.0b013e3181f052d4
49. Garcia-Aguilar J., Marcet J., Coutsoftides T., Impact of neoadjuvant chemotherapy following chemoradiation on tumor response, adverse events, and surgical complications in patients with advanced rectal cancer treated with total mesorectal excision. Journal of Clinical Oncology 2011 29. Abstract no. 3514